This compound is primarily utilized as a chiral catalyst or ligand in asymmetric synthesis, particularly in organic transformations where enantioselectivity is crucial. It is often employed in the development of pharmaceuticals, where the production of specific enantiomers is essential for drug efficacy and safety. Its unique structure allows it to effectively induce chirality in reactions such as hydrogenations, cycloadditions, and other carbon-carbon bond-forming processes. Additionally, it finds application in academic research for studying enantioselective mechanisms and developing novel catalytic methods. Its trifluoromethyl groups enhance its stability and reactivity, making it a valuable tool in synthetic organic chemistry.